Hold For Now: Shattuck Labs' SL-172154 Potential In Early Trials [Seeking Alpha]
Shattuck Labs, Inc. (STTK)
Company Research
Source: Seeking Alpha
SL-172154, their flagship candidate, is in Phase 1 trials and shows a promising anti-tumor immune response. The collaboration with Ono Pharmaceutical secures up to $227 million in milestone payments and R&D funding. Financially, Shattuck Labs has $114.6 million in liquidity but faces a significant cash burn rate. While the potential is high, early-stage IP and financial risks suggest a "hold" rating. Shattuck Labs, Inc. ( NASDAQ: STTK ) developed a proprietary Agonist Redirected Checkpoint [ARC] platform to create bi-functional fusion proteins to treat cancer and autoimmune diseases. STTK's flagship candidate is SL-172154 in Phase 1 clinical trials for aggressive cancers. These trials leverage the drug's dual functionality Recommended For You Recommended For You
Show less
Read more
Impact Snapshot
Event Time:
STTK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STTK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STTK alerts
High impacting Shattuck Labs, Inc. news events
Weekly update
A roundup of the hottest topics
STTK
News
- Shattuck Labs, Inc. (NASDAQ:STTK) is definitely on the radar of institutional investors who own 43% of the company [Yahoo! Finance]Yahoo! Finance
- Shattuck Labs, Inc. (NASDAQ: STTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.MarketBeat
- Shattuck Labs, Inc. (NASDAQ: STTK) had its price target lowered by analysts at Citigroup Inc. from $9.00 to $8.00. They now have a "buy" rating on the stock.MarketBeat
- Shattuck Labs, Inc. (NASDAQ: STTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $8.00 price target on the stock.MarketBeat
- Shattuck Labs, Inc. (NASDAQ: STTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.MarketBeat
STTK
Earnings
- 2/29/24 - Beat
STTK
Sec Filings
- 8/16/24 - Form SC
- 8/1/24 - Form 10-Q
- 8/1/24 - Form 8-K
- STTK's page on the SEC website